![](/img/cover-not-exists.png)
A 24-week double-blind placebo-controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms
Bernard, Katy, Gouttefangeas, Sylvie, Bretin, Sylvie, Galtier, Stéphanie, Robert, Philippe, Holthoff-Detto, Vjera, Cummings, Jeffrey, Pueyo, MariaVolume:
5
Year:
2019
Language:
english
Journal:
Alzheimer's & Dementia: Translational Research & Clinical Interventions
DOI:
10.1016/j.trci.2019.04.002
File:
PDF, 1.06 MB
english, 2019